These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 16954438)

  • 41. Collagen-induced differential expression of an RNA polymerase subunit by breast cancer cells.
    Sirchia R; Luparello C
    Biochimie; 2005 Aug; 87(8):669-72. PubMed ID: 15885872
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intronic enhancement of angiotensin II type 2 receptor transgene expression in vitro and in vivo.
    Li HW; Gao YX; Raizada MK; Sumners C
    Biochem Biophys Res Commun; 2005 Oct; 336(1):29-35. PubMed ID: 16122703
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Angiotensin modulates human mammary epithelial cell motility.
    Piastowska-Ciesielska AW; Domińska K; Nowakowska M; Gajewska M; Gajos-Michniewicz A; Ochędalski T
    J Renin Angiotensin Aldosterone Syst; 2014 Dec; 15(4):419-29. PubMed ID: 23390187
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bauhinia forficata lectin (BfL) induces cell death and inhibits integrin-mediated adhesion on MCF7 human breast cancer cells.
    Silva MC; de Paula CA; Ferreira JG; Paredes-Gamero EJ; Vaz AM; Sampaio MU; Correia MT; Oliva ML
    Biochim Biophys Acta; 2014 Jul; 1840(7):2262-71. PubMed ID: 24641823
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Integrin beta1 upregulation in MCF-7 breast cancer cells by angiotensin II.
    Berry MG; Goode AW; Puddefoot JR; Vinson GP; Carpenter R
    Eur J Surg Oncol; 2000 Feb; 26(1):25-9. PubMed ID: 10718175
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Understanding the role of integrins in breast cancer invasion, metastasis, angiogenesis, and drug resistance.
    Yousefi H; Vatanmakanian M; Mahdiannasser M; Mashouri L; Alahari NV; Monjezi MR; Ilbeigi S; Alahari SK
    Oncogene; 2021 Feb; 40(6):1043-1063. PubMed ID: 33420366
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prolactin-Induced Protein regulates cell adhesion in breast cancer.
    Vanneste M; Naderi A
    Biochem Biophys Res Commun; 2015 Dec; 468(4):850-6. PubMed ID: 26585492
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rethinking the development of breast cancer.
    Schehr RS
    Nat Biotechnol; 1997 Jun; 15(6):517-8. PubMed ID: 9181570
    [No Abstract]   [Full Text] [Related]  

  • 49. Angiotensin II facilitates breast cancer cell migration and metastasis.
    Rodrigues-Ferreira S; Abdelkarim M; Dillenburg-Pilla P; Luissint AC; di-Tommaso A; Deshayes F; Pontes CL; Molina A; Cagnard N; Letourneur F; Morel M; Reis RI; Casarini DE; Terris B; Couraud PO; Costa-Neto CM; Di Benedetto M; Nahmias C
    PLoS One; 2012; 7(4):e35667. PubMed ID: 22536420
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preparation, Radiolabeling with
    Okarvi SM
    Pharmaceuticals (Basel); 2023 Nov; 16(11):. PubMed ID: 38004416
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The renin-angiotensin-aldosterone system (RAAS) signaling pathways and cancer: foes versus allies.
    Hassani B; Attar Z; Firouzabadi N
    Cancer Cell Int; 2023 Oct; 23(1):254. PubMed ID: 37891636
    [TBL] [Abstract][Full Text] [Related]  

  • 52. AGTR1 promotes lymph node metastasis in breast cancer by upregulating CXCR4/SDF-1α and inducing cell migration and invasion.
    Ma Y; Xia Z; Ye C; Lu C; Zhou S; Pan J; Liu C; Zhang J; Liu T; Hu T; Xie L; Wu G; Zhao Y
    Aging (Albany NY); 2019 Jun; 11(12):3969-3992. PubMed ID: 31219799
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Angiotensin II promotes ovarian cancer spheroid formation and metastasis by upregulation of lipid desaturation and suppression of endoplasmic reticulum stress.
    Zhang Q; Yu S; Lam MMT; Poon TCW; Sun L; Jiao Y; Wong AST; Lee LTO
    J Exp Clin Cancer Res; 2019 Mar; 38(1):116. PubMed ID: 30845964
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antihypertensive drug use and breast cancer risk: a meta-analysis of observational studies.
    Ni H; Rui Q; Zhu X; Yu Z; Gao R; Liu H
    Oncotarget; 2017 Sep; 8(37):62545-62560. PubMed ID: 28977968
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Repurposing ARBs as treatments for breast cancer.
    George AJ; Allen A; Chand AL
    Aging (Albany NY); 2017 May; 9(5):1357-1358. PubMed ID: 28562314
    [No Abstract]   [Full Text] [Related]  

  • 56. Association between AT1 and AT2 angiotensin II receptor expression with cell proliferation and angiogenesis in operable breast cancer.
    Arrieta O; Villarreal-Garza C; Vizcaíno G; Pineda B; Hernández-Pedro N; Guevara-Salazar P; Wegman-Ostrosky T; Villanueva-Rodríguez G; Gamboa-Domínguez A
    Tumour Biol; 2015 Jul; 36(7):5627-34. PubMed ID: 25682288
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of angiotensin receptor blockade on prevention and reversion of tamoxifen-resistant phenotype in MCF-7 cells.
    Namazi S; Sahebi E; Rostami-Yalmeh J; Jaberipour M; Razmkhah M; Hosseini A; Arabsolghar R
    Tumour Biol; 2015 Feb; 36(2):893-900. PubMed ID: 25304158
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lowered cancer risk with ACE inhibitors/ARBs: a population-based cohort study.
    Chiang YY; Chen KB; Tsai TH; Tsai WC
    J Clin Hypertens (Greenwich); 2014 Jan; 16(1):27-33. PubMed ID: 24304931
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Use of ACE Inhibitors and Angiotensin Receptor Blockers and Primary Breast Cancer Outcomes.
    Chae YK; Brown EN; Lei X; Melhem-Bertrandt A; Giordano SH; Litton JK; Hortobagyi GN; Gonzalez-Angulo AM; Chavez-Macgregor M
    J Cancer; 2013; 4(7):549-56. PubMed ID: 23983819
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A conceptually new treatment approach for relapsed glioblastoma: coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative for Accelerated Improvement of Glioblastoma Care.
    Kast RE; Boockvar JA; Brüning A; Cappello F; Chang WW; Cvek B; Dou QP; Duenas-Gonzalez A; Efferth T; Focosi D; Ghaffari SH; Karpel-Massler G; Ketola K; Khoshnevisan A; Keizman D; Magné N; Marosi C; McDonald K; Muñoz M; Paranjpe A; Pourgholami MH; Sardi I; Sella A; Srivenugopal KS; Tuccori M; Wang W; Wirtz CR; Halatsch ME
    Oncotarget; 2013 Apr; 4(4):502-30. PubMed ID: 23594434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.